Xinhui Chen

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi et al. · Clinical Cancer Research · 2021 · 328 citations · Full text

An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis

Song Zhu, Jizhong Wang, De Chen et al. · Nature Communications · 2020 · 242 citations · Full text

Investigating interior driving factors and cross-industrial linkages of carbon emission efficiency in China's construction industry: Based on Super-SBM DEA and GVAR model

Yinxiang Zhou, Weili Liu, Xuying Lv et al. · Journal of Cleaner Production · 2019 · 213 citations

Super-sbm Dea, Engineering, Environmental Impact Assessment +9

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Funda Meric‐Bernstam, Randy F. Sweis, Stefan Kasper et al. · Clinical Cancer Research · 2022 · 205 citations · Full text

Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State

Sharon M. Seifert, Xinhui Chen, Amie L. Meditz et al. · AIDS Research and Human Retroviruses · 2016 · 80 citations · Full text